Kymera Therapeutics Inc (KYMR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 47,976 | 156,819 | 84,903 | 53,098 | 31,004 |
| Marketable Securities | 394,442 | 379,567 | 274,204 | 280,439 | 265,198 |
| Receivables | N/A | N/A | N/A | 856 | 577 |
| Other current assets | 135 | 1,573 | 904 | 878 | 856 |
| TOTAL | $451,273 | $543,731 | $364,806 | $340,791 | $302,339 |
| Non-Current Assets | |||||
| PPE Net | 11,881 | 12,184 | 12,118 | 10,752 | 10,841 |
| Investments And Advances | 125,187 | 74,692 | 45,305 | 101,639 | 162,531 |
| Other Non-Current Assets | 17,564 | 11,846 | 12,157 | 11,370 | 11,464 |
| TOTAL | $154,632 | $98,722 | $69,580 | $123,761 | $184,836 |
| Total Assets | $605,905 | $642,453 | $434,386 | $464,552 | $487,175 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,005 | 5,033 | 8,177 | 8,348 | 4,368 |
| Accrued Expenses | 22,971 | 19,219 | 14,668 | 10,572 | 10,330 |
| Other current liabilities | 228 | 375 | 114 | 257 | 106 |
| TOTAL | $92,542 | $94,493 | $108,685 | $110,137 | $110,617 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 61,739 | 66,234 | 82,263 | 87,912 | 92,552 |
| Other Non-Current Liabilities | 13,290 | 13,539 | 13,780 | 14,016 | 14,228 |
| TOTAL | $53,725 | $64,825 | $67,597 | $79,168 | $92,670 |
| Total Liabilities | $146,267 | $159,318 | $176,282 | $189,305 | $203,287 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 51,704 | 51,387 | 51,040 | 45,030 | 44,811 |
| Common Shares | 5 | 5 | 5 | 4 | 4 |
| Retained earnings | -228,982 | -195,082 | -166,500 | -141,840 | -128,765 |
| Other shareholders' equity | -660 | -146 | 0 | -13 | -128 |
| TOTAL | $459,638 | $483,135 | $258,104 | $275,247 | $283,888 |
| Total Liabilities And Equity | $605,905 | $642,453 | $434,386 | $464,552 | $487,175 |